Correlation Between CICC Fund and BrightGene Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CICC Fund and BrightGene Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CICC Fund and BrightGene Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CICC Fund Management and BrightGene Bio Medical, you can compare the effects of market volatilities on CICC Fund and BrightGene Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CICC Fund with a short position of BrightGene Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of CICC Fund and BrightGene Bio.

Diversification Opportunities for CICC Fund and BrightGene Bio

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between CICC and BrightGene is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding CICC Fund Management and BrightGene Bio Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrightGene Bio Medical and CICC Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CICC Fund Management are associated (or correlated) with BrightGene Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrightGene Bio Medical has no effect on the direction of CICC Fund i.e., CICC Fund and BrightGene Bio go up and down completely randomly.

Pair Corralation between CICC Fund and BrightGene Bio

Assuming the 90 days trading horizon CICC Fund Management is expected to generate 0.52 times more return on investment than BrightGene Bio. However, CICC Fund Management is 1.92 times less risky than BrightGene Bio. It trades about 0.35 of its potential returns per unit of risk. BrightGene Bio Medical is currently generating about -0.02 per unit of risk. If you would invest  327.00  in CICC Fund Management on October 30, 2024 and sell it today you would earn a total of  63.00  from holding CICC Fund Management or generate 19.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CICC Fund Management  vs.  BrightGene Bio Medical

 Performance 
       Timeline  
CICC Fund Management 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in CICC Fund Management are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, CICC Fund sustained solid returns over the last few months and may actually be approaching a breakup point.
BrightGene Bio Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BrightGene Bio Medical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, BrightGene Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

CICC Fund and BrightGene Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CICC Fund and BrightGene Bio

The main advantage of trading using opposite CICC Fund and BrightGene Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CICC Fund position performs unexpectedly, BrightGene Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrightGene Bio will offset losses from the drop in BrightGene Bio's long position.
The idea behind CICC Fund Management and BrightGene Bio Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets